Blog

30 November, 2020

The Royal Decree that regulates observational studies with medicines for human use approved

Source: www.noticias.juridicas.com Royal Decree 957/2020, of November 3, establishes the conditions that must be met to proceed with the evaluation, performance and monitoring of observational studies […]
19 November, 2020

Eight drug projects of small Spanish companies attract the interest of pharmaceutical companies

New meeting of the Farma-Biotech program, which brings start-ups and research groups into contact with national and international pharmaceutical companies to promote preclinical research and facilitate […]
9 November, 2020

Regulatory alignment and mutual recognition for the manufacture of medicines, needs of the pharmaceutical industry in the face of ‘Brexit’

Pharmaceutical companies are working to ensure seamless access to medicines ahead of the UK’s exit from the EU, due in January Farmaindustria and the British Embassy […]
6 November, 2020

Takeda launches a website that groups all its clinical trials

So, in an exercise of transparency, anyone can have access to this data Carmen Montoto, Takeda Medical Director in Spain Source: www.redaccionmedica.com As part of its […]
23 October, 2020

Farmaindustria bets on digitization to consolidate Spain in drug trials

In the workshop “Digital challenges in the management of clinical trials”, organized by Farmaindustria, its attendees have shown their commitment to digitization to help Spain consolidate […]
21 October, 2020

BMS celebrates the first international forum aimed at the research community of Spain and Portugal

The objective of this meeting has been to present the latest advances in the area of Oncology with experts of national and international origin and to […]
20 October, 2020

Research in breast cancer: more survival and better quality of life

Nine out of ten women diagnosed in Spain survive to 5 years The development of more precise, effective treatments with fewer side effects, together with the […]
5 October, 2020

Covid-19 has delayed cancer clinical trial programs

  Source: www.redaccionmedica.com María Blasco recalls that investment in science “is not even at the levels prior to 2010” Scientists gathered at the meeting ‘A new […]
2 October, 2020

Immunotherapy before surgery doubles survival in lung cancer

A Spanish study “opens a door in a global therapeutic approach” that would allow more patients to be cured Source: www.redaccionmedica.com The survival prospects of patients […]
28 September, 2020

The fight against cancer is not stopped by the coronavirus: four out of ten new investigational drugs are antitumor

Even in the harshest months of the pandemic, pharmaceutical companies have continued to promote studies to admit patients, when it was the only therapeutic alternative for […]
17 September, 2020

Comprehensive commitment of the pharmaceutical industry to patient safety

Clinical trials, pharmacovigilance and verification are just some of the fields of action where pharmaceutical companies actively work to guarantee the well-being of people in their […]
15 September, 2020

Arranca el primer ensayo en humanos de una vacuna Covid-19 en España

Janssen’s coronavirus vaccine will be tested in 190 Spanish volunteers and the study will last between 4 and 6 months Source: www.redaccionmedica.com Spain begins, this week, […]